Supplementary Figure 2. 0.05mg/mL EMP9 couldn't completely deprive the anti-inflammatory function of pHBSP. A-B:
Undifferentiated cells were induced to differentiate into mature 3T3-L1 pre-adipocytes by treatment with MDI for 8 hours followed by insulin supplementation, and data shows that administration of 0.05mg/mL EMP9 deprived the effect of 25 and 50nM pHBSP on PPAR-γ and TNF-α expression, while didn't deprive 100nM pHBSP on PPAR-γ and TNF-α expression in 3T3-L1 cells. C-D: Peritoneal macrophages were treated with 1μg/mL LPS followed by 0.05mg/mL EMP9 as well as various doses of pHBSP or PBS/scrambled peptide control intervention with for 4 hours, and data shows that administration of 0.05mg/mL EMP9 deprived the effect of 25 and 50nM pHBSP on PPAR-γ and TNF-α expression, while didn't deprive 100nM pHBSP on PPAR-γ and TNF-α expression in peritoneal macrophages. N= 3 per group; PM indicates peritoneal macrophages; SP indicates scrambled peptide; data are mean ± SEM; error bars indicate s.e.m. and significance is indicated by *P < 0.05 determined by one-way analysis of variance, followed by Dunnett's multiple comparison test.
